Evolus EOLS
NASDAQ EOLS
$7.38 +0.57 (+8.37%)
As of: Nov 11, 2026 · 3:54 PM EST

Evolus (EOLS) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Evolus (EOLS) posted Return on Capital Employed [ROCE] of -12.63% for Q3 2026, up 12.31 percentage points from -24.94% a year earlier and up 1.14 percentage points from the prior quarter.

Analysis

Evolus (EOLS) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Evolus' Return on Capital Employed [ROCE] came in at -21.22%, up 2.06 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for three consecutive years, with a five-year change of +322.70 percentage points (FY2020 to FY2025).
  • In prior years, Evolus' Return on Capital Employed [ROCE] was -23.28% in FY2024 (+13.14 pp), -36.42% in FY2023 (+1.74 pp), -38.15% in FY2022 (-12.87 pp) and -25.29% in FY2021 (+318.63 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q1 2018.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last three quarters, with an average year-over-year change of +6.01 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2021, with a gain of 450.88 percentage points; the weakest was Q4 2022, with a drop of 22.20 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -13.77% (Q2 2026), -15.68% (Q1 2026) and -22.20% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Evolus 450.43 Mn 259.94 Mn 50.69 Mn -12.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -12.63%
Jun 30, 2026 -13.77%
Mar 31, 2026 -15.68%
Dec 31, 2025 -22.20%
Sep 30, 2025 -24.94%
Jun 30, 2025 -27.44%
Mar 31, 2025 -24.39%
Dec 31, 2024 -20.47%
Sep 30, 2024 -23.84%
Jun 30, 2024 -22.01%
Mar 31, 2024 -28.68%
Dec 31, 2023 -37.82%
Sep 30, 2023 -42.72%
Jun 30, 2023 -45.18%
Mar 31, 2023 -48.21%
Dec 31, 2022 -47.05%
Sep 30, 2022 -48.30%
Jun 30, 2022 -45.01%
Mar 31, 2022 -34.22%
Dec 31, 2021 -24.85%
API Access

Evolus Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEY